Crossmark

Evaluation of the efficacy and safety of different doses of daily paroxetine in patients with lifelong premature ejaculation: a prospective randomized crossover study

Crossref DOI link: https://doi.org/10.1007/s11255-025-04921-4

Published Online: 2025-12-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

GamalEl Din, Sameh Fayek

Sadek, Ahmed Raef

Elamir, Mohamed Yousry

Ateya, Mohamed Ahmed

Saber, Hesham Hanafy

Ghaly, Mahmoud Fawzy
License Information

Text and Data Mining valid from 2025-12-04

Version of Record valid from 2025-12-04
More Information

Article History

Received: 22 September 2025

Accepted: 16 November 2025

First Online: 4 December 2025

Declarations

:

: The authors declare that they have no conflict of interest.

: All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the local ethical committee.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below